How to Tell if a Semaglutide Side Effect Is Serious

Red Flags: Go to the ER

These symptoms require immediate medical evaluation. They are rare with semaglutide, but recognizing them early matters.

Severe abdominal pain radiating to the back. This is the hallmark of acute pancreatitis. The pain is typically in the upper abdomen, feels like it bores straight through to the back, and is not relieved by position changes or antacids. Pancreatitis occurred in 0.2% of semaglutide patients in the STEP 1 trial. It is uncommon but serious.

Cannot keep any liquids down for 24+ hours. Vomiting that prevents all fluid intake creates a dehydration emergency. Semaglutide has a long half-life (7 days), meaning you cannot simply wait for it to clear your system. If you cannot sip water or electrolyte solution without vomiting it back, you need IV fluids.

Signs of severe allergic reaction. Facial or throat swelling, difficulty breathing, widespread hives, or rapid heartbeat with dizziness. Anaphylaxis to semaglutide is extremely rare but requires epinephrine and emergency care.

Sudden vision changes (diabetic patients). Rapid blood sugar improvement can temporarily worsen diabetic retinopathy. If you have diabetes and experience sudden blurred vision, floaters, or vision loss after starting semaglutide, get an urgent ophthalmology evaluation. See our diabetic patients guide for more context.

Yellow Flags: Call Your Doctor Within 24 Hours

Persistent vomiting beyond 48 hours. Some vomiting during dose increases is expected. Vomiting that does not improve after 48 hours suggests the dose may be too high or another issue may be contributing. Your provider may recommend stepping back to the previous dose.

Signs of dehydration. Dark amber urine, dizziness when standing, dry mouth that does not improve with drinking, rapid heartbeat at rest, or confusion. Dehydration compounds every other semaglutide side effect and can become dangerous independently.

Upper right abdominal pain after eating. This pattern suggests gallbladder involvement. Rapid weight loss increases gallstone risk, and gallbladder events occurred in approximately 2.6% of STEP trial patients. The pain typically comes 30 to 60 minutes after fatty meals. FormBlends monitors for this pattern during treatment.

Severe constipation lasting 7+ days. Constipation that does not respond to increased fluids, fiber, and OTC options like MiraLAX may indicate a more significant bowel motility issue. Rarely, severe constipation can progress to bowel obstruction.

Heart rate changes. Semaglutide can increase resting heart rate by 1 to 4 beats per minute on average. If you notice your resting heart rate is consistently 15+ beats above your baseline, or you experience palpitations with lightheadedness, contact your provider.

Green Flags: Normal Adjustment, Manage at Home

Mild to moderate nausea that comes and goes. This is the most common semaglutide experience, affecting up to 44% of patients at higher doses. It typically peaks at days 3 to 5 after injection or dose increase and resolves by days 7 to 14. Ginger, small meals, and avoiding fatty foods are your first-line tools.

Reduced appetite. This is the intended therapeutic effect. If your appetite is significantly lower but you can still eat adequate protein and stay hydrated, this is the medication working as designed.

Temporary fatigue. Common during the first 2 to 4 weeks and at dose increases. Usually related to reduced caloric intake as your body adjusts to eating less. Ensuring adequate protein (60-80g daily minimum) and hydration helps resolve it.

Mild constipation. Responds to increased water intake (64+ ounces daily), fiber supplementation, and walking. If you are having bowel movements at least every 3 days and they are not painful, home management is appropriate. See our constipation guide for detailed strategies.

Injection site redness or mild bruising. Normal reaction that resolves in 1 to 3 days. Rotating injection sites and allowing the pen to reach room temperature before injecting can minimize this.

The Decision Tree

Pancreatitis: The Side Effect Everyone Worries About

Pancreatitis is the most searched serious side effect of semaglutide, and the fear is disproportionate to the risk. In the STEP 1 trial, acute pancreatitis occurred in 0.2% of semaglutide patients compared to 0.1% in the placebo group. That is an absolute increase of 1 additional case per 1,000 patients treated.

The symptoms are distinctive: severe epigastric pain that radiates to the back, often accompanied by vomiting, and typically worse after eating. The pain does not respond to antacids or position changes. It is qualitatively different from the mild GI discomfort of normal semaglutide adjustment.

Patients with a history of pancreatitis, heavy alcohol use, or significantly elevated triglycerides are at higher baseline risk. FormBlends screens for these risk factors before prescribing and monitors lipase levels when clinically indicated.

Community Stories of Recognizing Serious Symptoms

When to Skip Your Next Dose

If you are experiencing any red flag symptoms, do not inject your next dose until you have spoken with your provider. Semaglutide has a 7-day half-life, meaning the current dose will remain active for several more days even if you skip. Adding more medication on top of a serious reaction is never appropriate.

For yellow flag symptoms, contact your FormBlends provider before your next injection day. They may recommend skipping one dose, dropping back to the previous dose level, or continuing with supportive measures depending on the situation.

Green flag symptoms do not require skipping doses. Mild nausea, reduced appetite, and temporary fatigue are expected parts of the adjustment process. Skipping doses for mild symptoms delays your adaptation and can create a cycle of repeated adjustment periods. For more guidance on when stopping makes sense, see our when to stop article.

Frequently Asked Questions